Graduating from school is an exciting time, but lately, many graduates have struggled with their finances. To make ends meet as you enter a new phase of your life, you'll need to be smart with your money.
In the following video, Fool contributor Dan Caplinger gives several suggestions on what grads should do to improve their finances. From getting debt paid down to saving for long-term financial goals like a home or retirement, Dan notes the key advantage that most grads have on their side is time, and making the most of it can make a huge difference in your overall results.
Making the right financial decisions early in your life makes a world of difference in your golden years, but with most people chronically undersaving for retirement, it's clear not enough is being done. Don't make the same mistakes as the masses. Learn about The Shocking Can't-Miss Truth About Your Retirement. It won't cost you a thing, but don't wait, because your free report won't be available forever.
10 Best Semiconductor Stocks To Own For 2015: Kindred Healthcare Inc. (KND)
Kindred Healthcare, Inc. operates as a healthcare services company in the United States. The company�s Hospital division operates long-term acute care (LTAC) and inpatient rehabilitation (IRFs) hospitals, which provide services to medically complex patients, including the critically ill, suffering from multiple organ system failures, primarily the cardiovascular, pulmonary, kidney, gastro-intestinal, and skin systems, as well as life-threatening infections. Its Nursing Center division operates nursing and rehabilitation centers, and assisted living facilities that offer short stay patients and long stay residents with a range of medical, nursing, rehabilitative, pharmacy, and routine services. It also provides specialized programs for residents suffering from Alzheimer�s disease and other dementias through its reflections units. The company�s Rehabilitation division provides rehabilitation services, including physical and occupational therapies, and speech pathology ser vices under the RehabCare name to residents and patients of nursing centers, LTAC hospitals, outpatient clinics, home health agencies, assisted living facilities, school districts, and hospice providers. In addition, it offers specialized care programs that address medical needs, such as wound care, pain management, and cognitive retraining; and programs for neurologic, orthopedic, cardiac, and pulmonary conditions. Its Home Health and Hospice division offers home health, hospice, and private duty services to patients in various settings comprising homes, skilled nursing facilities, and other residential settings. As of December 31, 2011, it operated 121 LTAC hospitals with 8,597 licensed beds, and 5 IRFs with 183 licensed beds in 26 states; and 224 nursing and rehabilitation centers with 27,148 licensed beds, and 6 assisted living facilities with 413 licensed beds in 27 states. The company was founded in 1998 and is headquartered in Louisville, Kentucky.
Advisors' Opinion:- [By Anna Prior]
Kindred Healthcare Inc.(KND) boosted its offer to about $589 million to buy a smaller stake in Gentiva Health Services Inc.(GTIV), as it tries to draw the home health-care company to the negotiating table.
- [By Brad Thomas]
As the only healthcare REIT with a "hospital-focused" platform, MPW is a relatively new REIT that was formed (in 2004) to lease from many of the nation's leading hospital operators, including Prime Healthcare Services, Kindred Healthcare (KND), HealthSouth (HLS), Health Management Associates (HMA), Community Health Systems (CYH), Vibra Healthcare, Ernest Health Inc., and IASIS Healthcare.
Top Integrated Utility Companies To Buy For 2014: WebMD Health Corp (WBMD)
WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. The company?s public portals enable consumers to obtain health and wellness information, including information on specific diseases or conditions; check symptoms; locate physicians; store individual healthcare information; receive periodic e-newsletters on topics of individual interest; and participate in online communities with peers and experts. Its public portals for physicians and healthcare professionals provide access to clinical reference sources; stay abreast of the latest clinical information; learn about new treatment options; earn continuing medical education credit; and communicate with peers. The company also provides mobile health information applications for use by consumers and physicians. In addit ion, WebMD Health Corp. offers e-detailing promotion and physician recruitment services, content syndication and distribution, and information services, as well as print services, including the advertisements in WebMD the Magazine, a consumer magazine distributed to physician office waiting rooms. The public portals? sponsors and advertisers include pharmaceutical, biotechnology, medical device, and consumer products companies. The company?s private portals enable employers and health plans to provide their employees and members with access to personalized health and benefit information and decision support technology that helps them to make more informed benefit, treatment, and provider decisions. Further, it offers telephonic health coaching services on a per participant basis across an employee or plan population for clients of its private portals. The company was founded in 1995 and is headquartered in New York, New York.
Advisors' Opinion:- [By Steve Symington]
Of course, Epocrates isn't without competition:�WebMD's (NASDAQ: WBMD ) own Medscape app has also been downloaded more than 3 million times and, according to Medscape, is now used by half of all U.S. physicians, and three out of four U.S. medical students.
- [By Keith Speights]
For example, WebMD (NASDAQ: WBMD ) is working to create a new offering to provide customers with "seamlessly connected personal wireless health data." WebMD plans to use 2net to integrate data captured via medical devices into its network of mobile applications and websites.
Top Integrated Utility Companies To Buy For 2014: BlackRock Kelso Capital Corporation(BKCC)
BlackRock Kelso Capital Corporation is a private equity firm specializing in investments in middle market companies. The firm invests in all industries. It prefers to invest between $10 million and $50 million and can invest more or less in companies with EBITDA or operating cash flow between $10 million and $50 million. The firm invests in the form of senior and junior secured, unsecured, and subordinated debt securities and loans including cash flow, asset backed, and junior lien facilities and equity securities. It's equity investments can be structured in the form of warrants, preferred stock, common equity co-investments, and direct investments in common stock. The firm debt investments are principally structured to provide for current cash interest and to a lesser extent non-cash interest, particularly with subordinated debt investments, through a pay-in-kind (PIK) feature. It can also make non-control investments. Blackrock Kelso Capital Corporation was founded in 2 005 and is based in New York, New York with an additional office in Chicago, Illinois.
Advisors' Opinion:- [By Sally Jones]
Highlight: BlackRock Kelso Capital Corporation (BKCC)
The share price is currently $9.62 or 11.1% off the 52-week high of $10.82. Its yield is 10.80%.
Top Integrated Utility Companies To Buy For 2014: Dun & Bradstreet Corp (DNB)
The Dun & Bradstreet Corporation (D&B), incorporated on April 25, 2000, is the source of commercial information and insight on businesses, enabling customers to Decide with Confidence. As of December 31, 2012, the Company�� global commercial database contained more than 220 million business records. The database is enhanced by its DUNSRight Quality Process, which transforms commercial data into valuable insight which is the foundation of its global solutions. Customers use D&B Risk Management Solutions to mitigate credit and supplier risk, increase cash flow and drive profitability; D&B Sales & Marketing Solutions to provide data management capabilities that provide marketing solutions to increase revenue from new and existing customers, and D&B Internet Solutions to convert prospects into clients by enabling business professionals to research companies, executives and industries.
The Company operates in three segments: North America (which consists of its operations in the United States and Canada); Asia Pacific (which primarily consists of its operations in Australia, Greater China, India and Asia Pacific Worldwide Network), and Europe and other International Markets (which primarily consists of its operations in the United Kingdom, the Netherlands, Belgium, Latin America and its European Worldwide Network). The Company conducts its business internationally through its wholly owned subsidiaries, majority-owned joint ventures, independent correspondents, strategic relationships through its D&B Worldwide Network and minority equity investments.
Risk Management Solutions
The Company provides traditional, value-added and supply management solutions. The Company�� Traditional Risk Management Solutions, which primarily includes its core DNBi product line, as well as reports from its database which are used primarily for making decisions about new credit applications, constituted 74% of its Risk Management Solutions revenue and 47% of its total revenue for the ye! ar ended December 31, 2012. Its Value-Added Risk Management Solutions, which constituted 20% of its Risk Management Solutions revenue and 12% of its total revenue for the year ended December 31, 2012, generally support automated decision-making and portfolio management through the use of scoring and integrated software solutions. The Company�� Supply Management Solutions, which can help companies understand the financial risk of their supply chain, constituted 6% of its Risk Management Solutions revenue and 4% of its total revenue in 2012. Risk Management Solutions accounted for 63% of its total revenue in 2012.
Effective January 1, 2013, the Company began managing and reporting its North America Risk Management Solutions business as DNBi subscription plans, Non-DNBi subscription plans, and projects and other risk management solutions.
The Company�� principal Risk Management Solutions are DNBi, various business information reports, eRAM, and D&B Direct. DNBi is the Company�� interactive, customizable online application that offers customers a subscription based real time access to its complete and up-to-date global DUNSRight information, comprehensive monitoring and portfolio analysis. It is also focused on helping more customers protect their business from risk through additions of DNBi products: DNBi Corporate, offering flexible pricing options allowing credit departments of all sizes to get data and options they need and Portfolio Risk Manager for DNBi, a module which allows DNBi users to create strategic one -click analytic reports to see risk and opportunity across their customer base. Various business information reports include Business Information Report, its Comprehensive Report, and its International Report that are consumed in a transactional manner across multiple platforms, such as DNB.com. eRAM is an enterprise solution for large global and domestic customers for automated decisioning and portfolio analytics. D&B Direct is a software application programming inter! face (API! ) that enables data integration inside enterprise applications, such as ERP, and enables master data management.
Sales & Marketing Solutions
The Company�� Sales & Marketing Solutions is a customer solution set, which accounted 29% of its total revenue in 2012. Within this customer solution set, it offers traditional and value-added solutions. Its Traditional Sales & Marketing Solutions generally consist of its marketing lists and labels used by the Company�� customers in direct mail and marketing activities, its education business and its electronic licensing solutions. These solutions constituted 30% of its Sales & Marketing Solutions revenue and 9% of its total revenue in 2012. Effective January 1, 2013, The Company began managing and reporting its Internet Solutions business as part of its Traditional Sales & Marketing Solutions set. Its Value-Added Sales & Marketing Solutions generally include decision-making and customer information management solutions, including data management solutions like Optimizer (its solution to cleanse, identify and enrich its customers' client portfolios) and products introduced as part of its Data-as-a-Service (DaaS) Strategy, which integrates the Company�� data directly into the applications and platforms that its customers use every day. The Value-Added Sales & Marketing Solutions constituted 70% of Sales & Marketing Solutions revenue and 20% of its total revenue in 2012
Internet Solutions
The Company�� Internet Solutions business provides organized and easy-to-use products that address the online sales and marketing needs of professionals and businesses, including information on companies, industries and executives. Internet Solutions, primarily representing the results of its Hoover's business, accounted for 7% of its total revenue in 2012. Effective January 1, 2013, the Company began managing and reporting its Internet Solutions business as part of its Traditional Sales & Marketing Solutions set.
T! he Company competes with Equifax, Inc., Experian Information Solutions, Inc., infoGROUP, Graydon, and Sinotrust.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Dun & Bradstreet (NYSE: DNB ) , whose recent revenue and earnings are plotted below.
Top Integrated Utility Companies To Buy For 2014: Visteon Corporation(VC)
Visteon Corporation supplies automotive systems, modules, and components to automotive original equipment manufacturers worldwide. The company offers a range of electronics products, including audio/infotainment systems and components, such as base radio/CD head units, infotainment head units, audiophile systems and amplifiers, rear seat family entertainment systems, digital and satellite radios, HD and DAB broadcast tuners, MACH voice link technology, and connectivity solutions for portable devices; driver information systems comprising instrument clusters and displays to assist driving; and powertrain and feature control modules, including controllers for fuel pumps, transfer cases, tuning valves, and security and voltage regulation systems. It also provides electronic climate controls, such as single zone manual electronic and automatic multiple zone modules, as well as integrated audio and climate control assemblies; and lighting products consisting of headlamps, stop lamps, and fog lamps. In addition, the company offers integrated heating, ventilation, and air conditioning systems, which include evaporators, condensers, heater cores, climate controls, compressors, air handling cases, and fluid transport systems; and components and modules that provide cooling and thermal management for the vehicle?s engine and transmission, as well as for batteries and power electronics on hybrid and electric vehicles. Further, it provides interior products, including cockpit modules, which incorporate structural, electronic, climate control, mechanical, and safety components; door panels/modules and interior trim products; and console modules, which deliver storage options. The company was founded in 2000 and is headquartered in Van Buren Township, Michigan.
Advisors' Opinion:- [By David Sterman]
Auto parts maker Visteon (NYSE: VC) clearly embodies the new thinking about share buybacks. The company announced plans last month to sell its $1.5 billion stake in a joint venture with a Chinese partner. Visteon could have looked to pay down debt or make an acquisition, or simply keep the ($1.2 billion after-tax) proceeds. Instead, almost all of the money will go toward a share buyback that might reduce shares outstanding by 25%.
- [By Seth Jayson]
Visteon (NYSE: VC ) reported earnings on May 9. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Visteon beat expectations on revenues and crushed expectations on earnings per share.
Top Integrated Utility Companies To Buy For 2014: TESARO Inc (TSRO)
TESARO, Inc. (TESARO), incorporated in March 2010, is a development-stage, oncology-focused biopharmaceutical company for cancer patients. The Company focuses on rolapitant and TSR-011 product. The Company�� marketed products and product candidates in development treat cancer through non-specific damage to cellular components or alter cell metabolism or internal repair mechanisms to the demise of cancer cells.
Rolapitant
Rolapitant is a potent and long-acting neurokinin-1, or NK-1, receptor antagonist is in Phase III clinical trials for the prevention of chemotherapy induced nausea and vomiting (CINV). It is in Phase III clinical trials. CINV, if not prevented by prophylaxis, has the potential to afflict up to 90% or more of cancer patients undergoing chemotherapy, depending upon the type of chemotherapy administered the dosing schedule of the chemotherapy, and the patients' age and gender, among other predisposing factors. Prolonged nausea and vomiting may result in unwanted weight loss, dehydration and malnutrition, as well as hospitalization. The Company has in-licensed the rights to rolapitant from OPKO Health, Inc.
TSR-011
TSR-011 is an orally available ALK inhibitor in preclinical development. ALK is known to be involved in certain types of cancers, including subsets of NSCLC, neuroblastoma and lymphoma. For patients in these subsets, the ALK gene is fused to an activating partner or contains point mutations, resulting in constitutive activation of ALK and the growth of cancer cells and tumor development. Inhibition of ALK in these cancer cells results in cell death and tumor growth inhibition or regression. In August 2011, the United States Food and Drug Administration approved the first ALK inhibitor, developed by Pfizer Inc., Xalkori (crizotinib), which was approved for the treatment of patients with locally advanced or metastatic NSCLC that are ALK positive.
The Company competes with GlaxoSmithKline plc, Roche Holding Ltd! . and Sanofi S.A.
Advisors' Opinion:- [By Keith Speights]
Positive response
Clovis wasn't the only company to bring good news about an ovarian cancer drug to ASCO. TESARO� (NASDAQ: TSRO ) announced phase 1 results for�niraparib. Shares of the biotech jumped 16% for the week. - [By Brian Orelli]
Tesaro (NASDAQ: TSRO ) is also up today after announcing that it established a partnership with clinicians to run the phase 3 development of its PARP inhibitor, niraparib. The trial will enroll about 300 breast cancer patients with BRCA mutations, comparing niraparib to investigators' choice of other breast cancer treatments.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company TESARO (NASDAQ: TSRO ) has received the dreaded one-star ranking.
- [By Jake L'Ecuyer]
Equities Trading UP
Tesaro (NASDAQ: TSRO) shares shot up 20.78 percent to $29.00 after the company reported successful primary and secondary endpoints in final Phase 3 trial for rolapitant.
No comments:
Post a Comment